Listed by the USPTO as HAMMELL, NEIL P
Tech Center 1600 • Art Units: 1600 1634 1635 1636 1681
This examiner grants 35% of resolved cases
Neil P. Hammell is an examiner in Art Unit 1600 of Tech Center 1600. The examiner has 361 resolved cases and an allowance rate of 34.6%. The median time to allowance is 1233 days. This 34.6% allowance rate is relatively low, suggesting a rigorous examination standard.
The interview lift is 43.0%, which is a substantial increase over the base 34.6% allowance rate. This high lift suggests that interviews are a critical component of a successful prosecution strategy with this examiner. Top companies include University of Florida Research Foundation Inc., California Institute of Technology, and Friedrich Miescher Institute For Biomedical Research. These entities are often represented by firms like ALSTON & BIRD LLP, Hoffmann & Baron LLP, and HOXIE & ASSOCIATES LLC.
Practitioners should anticipate a long pendency, as the median time to allowance is 1233 days. Given the 43.0% interview lift, applicants are strongly encouraged to engage in direct dialogue to improve their chances. The 361 resolved cases provide a robust data set for these strategic conclusions.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17428749 | METHODS FOR TARGETED TREATMENT AND PREDICTION OF PATIENT SURVIVAL IN CANCER | Non-Final OA | University of Florida Research Foundation, Incorporated |
| 17264734 | ANTIBIOTIC SUSCEPTIBILITY OF MICROORGANISMS AND RELATED MARKERS, COMPOSITIONS, METHODS AND SYSTEMS | Final Rejection | California Institute of Technology |
| 17996276 | USE OF AN ORPHAN MOTIF TO INCREASE EXPRESSION OF A HETEROLOGOUS TRANSGENE | Non-Final OA | FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH |
| 18294325 | COMPOSITIONS AND METHODS FOR TREATING CMT1A OR CMT1E DISEASES WITH RNAI MOLECULES TARGETING PMP22 | Non-Final OA | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) |
| 17781480 | METHODS FOR IDENTIFYING MICROBES IN A CLINICAL AND NON-CLINICAL SETTING | Final Rejection | Biomiris Capital Group B.V. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy34.6% of resolved applications examined by Neil P Hammell were allowed (361 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +43.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Neil P Hammell took 1,233 days on average from filing to allowance.
Neil P Hammell examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).